CASSONDRA BARBARA: Open Payments
NPI 1902422256 · TONAWANDA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$380 in 18 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $346 · 2025 $380
Food & beverage: $380
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $77 |
| GlaxoSmithKline, LLC. | 4 | $67 |
| Insulet Corporation | 2 | $48 |
| Lilly USA, LLC | 2 | $36 |
| Exact Sciences Corporation | 1 | $28 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| ABBVIE INC. | 1 | $25 |
| Abbott Laboratories | 1 | $22 |
| Novo Nordisk Inc | 1 | $19 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
Products named: Kerendia, TRELEGY ELLIPTA, Omnipod, MOUNJARO, Cologuard Collection Kit, Auvelity, UBRELVY, FREESTYLE LIBRE 3.
Industry payments across NY — which companies pay providers there.
